| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 543,8 k € | +5.1% | 517,6 k € | +5.1% | 492,4 k € | +5.8% | 465,3 k € | — | — | — | — | — | — | — | — | — | 361,2 k € | +3.2% | 350,1 k € | +13.8% | 307,6 k € | |||||||||||
| Gross margin | 264,3 k € | +10.1% | 240,1 k € | -18.9% | 295,8 k € | +8.7% | 272,2 k € | -8.2% | 296,6 k € | +28.2% | 231,5 k € | +34.2% | 172,5 k € | -7.2% | 185,9 k € | -1.8% | 189,3 k € | +0.0% | 189,2 k € | -3.5% | 196,1 k € | +2.8% | 190,8 k € | +57.3% | 121,3 k € | -11.3% | 136,7 k € | -18.9% | 168,6 k € | +22.9% | 137,2 k € | |
| EBITDA | 255,9 k € | +15.3% | 221,9 k € | +52.8% | 145,2 k € | -24.4% | 192,1 k € | -14.8% | 225,4 k € | +34.6% | 167,4 k € | +51.9% | 110,2 k € | -10.8% | 123,5 k € | -4.1% | 128,8 k € | +2.7% | 125,5 k € | -2.9% | 129,2 k € | +4.1% | 124,1 k € | +141.0% | 51,5 k € | -32.4% | 76,1 k € | -30.8% | 110,1 k € | +16.3% | 94,7 k € | |
| Operating profit | 187,6 k € | +9.9% | 170,8 k € | +64.4% | 103,9 k € | -30.5% | 149,5 k € | -12.8% | 171,5 k € | +79.9% | 95,3 k € | +533.2% | 15,1 k € | -65.2% | 43,2 k € | -17.8% | 52,6 k € | -23.0% | 68,3 k € | +102.4% | 33,8 k € | -42.3% | 58,5 k € | +56883.8% | -103,0 € | -100.4% | 24,9 k € | -58.8% | 60,4 k € | -35.3% | 93,3 k € | |
| Profit/loss | 160,4 k € | +9.8% | 146,1 k € | +55.2% | 94,2 k € | -21.5% | 119,9 k € | -13.4% | 138,4 k € | +93.8% | 71,4 k € | +71159.0% | -100,5 € | -100.5% | 18,9 k € | -28.3% | 26,4 k € | -21.8% | 33,7 k € | +145.9% | 13,7 k € | -59.8% | 34,1 k € | +154.0% | 13,4 k € | -42.9% | 23,5 k € | +73.4% | 13,6 k € | -78.0% | 61,6 k € | |
| Equity | 904,1 k € | +21.6% | 743,7 k € | +20.2% | 618,6 k € | +14.7% | 539,4 k € | +22.7% | 439,5 k € | +33.6% | 329,1 k € | +27.7% | 257,7 k € | -0.0% | 257,8 k € | +7.9% | 238,9 k € | +12.4% | 212,5 k € | +18.9% | 178,7 k € | +8.3% | 165,0 k € | +26.1% | 130,8 k € | +11.5% | 117,4 k € | +25.1% | 93,9 k € | +16.9% | 80,3 k € | |
| Total assets | 1,3 M € | +7.6% | 1,2 M € | +43.9% | 862,7 k € | +10.2% | 783,2 k € | +10.2% | 710,9 k € | +12.6% | 631,2 k € | +1.5% | 622,1 k € | -4.3% | 650,3 k € | -3.8% | 676,2 k € | +4.4% | 647,6 k € | +2.3% | 632,8 k € | +76.0% | 359,6 k € | +25.1% | 287,4 k € | +11.3% | 258,1 k € | -5.4% | 272,8 k € | +199.6% | 91,0 k € | |
| Cash | 4,9 k € | -75.6% | 20,0 k € | +16.5% | 17,2 k € | -92.9% | 242,2 k € | +106.3% | 117,4 k € | +87.2% | 62,7 k € | +129.9% | 27,3 k € | -63.5% | 74,8 k € | +84.7% | 40,5 k € | -57.7% | 95,9 k € | +61.5% | 59,3 k € | -48.4% | 115,1 k € | +21.8% | 94,5 k € | +53.0% | 61,7 k € | +41.4% | 43,7 k € | +237.4% | 12,9 k € | |
| Debts | 428,1 k € | -13.5% | 494,9 k € | +104.6% | 241,9 k € | +1.3% | 238,9 k € | -9.8% | 264,7 k € | -11.0% | 297,6 k € | -18.2% | 363,7 k € | -7.4% | 392,5 k € | -10.3% | 437,4 k € | +0.5% | 435,1 k € | -4.2% | 454,1 k € | +133.3% | 194,6 k € | +24.4% | 156,5 k € | +11.2% | 140,7 k € | -21.3% | 178,9 k € | +1569.2% | 10,7 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 1 | 1 | 1 | 1 | 1 | 1 | 0,8 | ||||||||||||||||
Private limited company · Manage · incorporated on 16/02/2009
Private limited company profitable and well capitalised. Cash position declining (-75.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Joseph PUTMAN, docteur en médecine is a Private limited company incorporated in 2009. Its registered office is in Manage.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette